Prestige Wealth Management Group’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$26.2K Hold
379
0.01% 322
2025
Q1
$26.8K Hold
379
0.01% 314
2024
Q4
$32.6K Hold
379
0.01% 305
2024
Q3
$45.1K Hold
379
0.01% 256
2024
Q2
$54.1K Hold
379
0.01% 217
2024
Q1
$49K Hold
379
0.01% 254
2023
Q4
$39.2K Sell
379
-15
-4% -$1.55K 0.01% 263
2023
Q3
$35.8K Hold
394
0.01% 268
2023
Q2
$31.9K Hold
394
0.01% 306
2023
Q1
$31.6K Sell
394
-126
-24% -$10.1K 0.01% 276
2022
Q4
$35.2K Buy
520
+52
+11% +$3.52K 0.01% 285
2022
Q3
$23K Sell
468
-16
-3% -$786 0.01% 296
2022
Q2
$27K Hold
484
0.01% 292
2022
Q1
$27K Hold
484
0.01% 301
2021
Q4
$27K Hold
484
0.01% 330
2021
Q3
$23K Hold
484
0.01% 352
2021
Q2
$20K Hold
484
0.01% 363
2021
Q1
$16K Sell
484
-78
-14% -$2.58K ﹤0.01% 388
2020
Q4
$20K Sell
562
-22
-4% -$783 0.01% 355
2020
Q3
$20K Hold
584
0.01% 350
2020
Q2
$19K Sell
584
-10
-2% -$325 0.01% 343
2020
Q1
$18K Buy
594
+584
+5,840% +$17.7K 0.01% 296
2019
Q4
$0 Hold
10
﹤0.01% 639
2019
Q3
$0 Buy
+10
New ﹤0.01% 625
2019
Q2
Sell
-766
Closed -$20K 503
2019
Q1
$20K Sell
766
-142
-16% -$3.71K 0.01% 280
2018
Q4
$21K Buy
+908
New +$21K 0.02% 299